Results 201 to 210 of about 125,484 (349)
Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis
Arthritis &Rheumatology, EarlyView.Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley +1 more source
Fundic Gland Polyps Are Not Induced by Proton Pump Inhibitor Therapy [PDF]
, 2001 Michael Vieth, Manfred Stolte
openalex +1 more source
Biofuels, Bioproducts and Biorefining, EarlyView.Abstract The industrial production of citric acid, an ingredient in beverages, pharmaceuticals, and cosmetics, is based on microbial fermentation of glucose or sucrose. Given the elevated cost of these sugars, lignocellulosic biomass is emerging as a cost‐effective and environmentally friendly feedstock for sustainable bioprocesses.
Ludovica Varriale +4 more
wiley +1 more source
Problems Associated with the Clinical Use of Proton Pump Inhibitors [PDF]
, 2001 Derek Gillen, Kenneth E.L. McColl
openalex +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Deprescribing is complex because it involves patients' health, values, and preferences. The World Health Organization and Canadian Medication Appropriateness and Deprescribing Network have recommended that deprescribing be integrated into health curricula, prompting the need for further understanding about deprescribing education.
Brian J. Chow +3 more
wiley +1 more source
Does the use of proton pump inhibitors lead to an increased risk of dental implant failure? A systematic review and meta-analysis. [PDF]
Med Oral Patol Oral Cir BucalTang M, Xie Z.
europepmc +1 more source
Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in brazilian patients with peptic ulcer [PDF]
, 2001 Fernando Marcuz Silva +5 more
openalex +1 more source
Medications, epilepsy and climate change: Added layers of complexity
British Journal of Clinical Pharmacology, EarlyView.Climate change—the global crisis with pervasive health impacts—has adverse consequences for people with epilepsy (PWE) who have low quality of life due to poor seizure control, socioeconomic disadvantages and comorbidities. This review focuses on the potential effects of climate change on the pharmacological characteristics of antiseizure medications ...
Medine I. Gulcebi +2 more
wiley +1 more source